Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors

E-ISSN： 1875-533x|7|3|303-339

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.7, Iss.3, 2000-03, pp. : 303-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease

By Heydorn W.E.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1527-1537

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats

By Kosasa T. Kuriya Y. Matsui K. Yamanishi Y.

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 173-179

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats

By Kosasa T. Kuriya Y. Matsui K. Yamanishi Y.

European Journal of Pharmacology, Vol. 386, Iss. 1, 1999-12 ,pp. : 7-13

Elsevier

Access to resources Recommend Favorite

Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats

By Kosasa T. Kuriya Y. Matsui K. Yamanishi Y.

European Journal of Pharmacology, Vol. 380, Iss. 2, 1999-09 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

Clinical benefits are maintained during long-term treatment of Alzheimer's disease with the acetylcholinesterase inhibitor, E2020

By Rogers S.L. Perdomo C. Friedhoff L.T.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 386-387

Elsevier

Access to resources Recommend Favorite